Bruker Daltonics Appoints Michael Schubert as Executive Vice President and Ian Sanders as Vice President


Bruker Daltonics Inc. announced two promotions to further strengthen its senior management team.

Dr. Michael Schubert has been promoted to Executive Vice President of the Bruker Daltonics group. He retains his previous responsibilities for Bruker Daltonics' global R&D management, as well as his function as Managing Director (Geschaeftsfuehrer) of Bruker Daltonik GmbH, located in Bremen and Leipzig, Germany. In addition, Dr. Schubert now also assumes responsibility for the Company's life-science mass spectrometry business in the Americas. Dr. Schubert joined Bruker Daltonics in 1991, and has held several project and R&D management positions. In 2002, he became Managing Director of Bruker Daltonik GmbH, and in 2004 Vice President for R&D of Bruker Daltonics. He holds a doctorate from the University of Hamburg in physics.

Ian Sanders, Ph.D., has been promoted to Vice President for European Life Science Sales, a function that he has previously managed as an Assistant Vice President. He also continues in his role as Managing Director of Bruker Daltonik GmbH. Dr. Sanders joined Bruker Daltonics in 2000 following a ten-year career in drug discovery research for both large pharmaceutical and venture biotechnology companies. Initially responsible for the UK business, in 2002 his role expanded to manage life-science sales in the UK, Scandinavia and The Netherlands. In 2004, he became Assistant Vice President for European Life-Science Sales, and in 2005, Managing Director of Bruker Daltonik GmbH. He holds a Ph.D. in drug discovery technology from The University of Bath, UK.

Other news from the department people

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics